4 Midcap Rs 2,000-10,000 Crore Revenue Stocks to Watch for Future Multibagger Potential: Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC
- October 27, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Max Healthcare Rs 835. MCX Rs 3,111.80. Phoenix Mills Rs 1,894. Nippon Life India AMC Rs 919.10. Market caps from Rs 63,904 crore to Rs 85,241 crore. Data as of 26 Oct 2026.
Quick Answer
Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC are the 4 picks in this Rs 2,000-10,000 crore revenue stocks watchlist, with market caps between Rs 63,904 crore and Rs 85,241 crore. Max Healthcare stands out for the largest market cap at Rs 85,241 crore, while MCX offers the highest return on equity at 46.75%. PE ratios run from 39.03 to 58.50, so compare each one with its industry PE before investing. All figures are as of 26 October 2026.
Rs 2,000-10,000 crore revenue stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC meet that test, with market caps from Rs 63,904 crore to Rs 85,241 crore and Max Healthcare offering the largest market cap at Rs 85,241 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 revenue between Rs 2,000 crore and Rs 10,000 crore, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 revenue between Rs 2,000 crore and Rs 10,000 crore, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening Rs 2,000-10,000 crore revenue stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 26 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Rs 2,000-10,000 Crore Revenue Stocks and Why Do They Attract Multibagger Interest?
Rs 2,000-10,000 crore revenue stocks are shares of mid sized companies with FY26 sales between Rs 2,000 crore and Rs 10,000 crore, a size where a business is proven and still has room to scale. The four here cover hospitals, a commodity exchange, malls and asset management.
This sales range holds focused businesses that have outgrown the start-up stage but can still compound for years. Within Rs 2,000-10,000 crore revenue stocks, the four companies show rising profit. For Rs 2,000-10,000 crore revenue stocks, both FY26 and the latest quarter showed growth. Whichever way you read Rs 2,000-10,000 crore revenue stocks, the common thread is rising profit backed by complete financial data. For Rs 2,000-10,000 crore revenue stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of Rs 2,000-10,000 crore revenue stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for Rs 2,000-10,000 crore revenue stocks before you decide.
Rs 2,000-10,000 Crore Revenue Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 26 October 2026. Nippon Life India AMC has the lowest PE of the group at 39.03, while MCX posts the highest return on equity at 46.75%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Max Healthcare Institute | 835 | 85,241 | 58.50 | 60.75 | 13.42% | 0.32 | 815.00 to 1,221.90 |
| Multi Commodity Exchange of India | 3,111.80 | 80,572 | 52.26 | 42.17 | 46.75% | 0.00 | 1,762.10 to 3,481.40 |
| Phoenix Mills | 1,894 | 68,592 | 42.08 | 31.56 | 11.14% | 0.48 | 1,465.60 to 2,169.80 |
| Nippon Life India Asset Management | 919.10 | 63,904 | 39.03 | 17.70 | 32.83% | 0.02 | 795.80 to 1,269.50 |
Max Healthcare: 24.26% Profit CAGR Since FY22
Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.
In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026. The stock trades at a PE of 58.50 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%.
MCX: 74.55% Profit CAGR Since FY22
MCX is India’s leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
The stock trades at a PE of 52.26 against an industry PE of 42.17, with a return on equity of 46.75%. In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026.
Phoenix Mills: 58.28% Profit CAGR Since FY22
Phoenix Mills owns and runs large retail malls across India under the Phoenix Marketcity and Palladium brands, along with offices, hotels and residences. It reported FY26 revenue of Rs 4,593.55 crore, up 15.87% year on year, and net profit of Rs 1,556.61 crore, up 19.60%. Net profit has compounded at 58.28% a year since FY22, while revenue has grown 31.04% a year. Operating margin was 62.83% in FY26. The debt-to-equity ratio is 0.48.
In the June 2026 quarter, revenue rose 13.27% to Rs 1,115.15 crore and net profit grew 23.02% to Rs 393.55 crore. The share price has gained 303.49% over five years and 11.92% over the past year. Domestic institutions raised their holding from 15.47% in September 2025 to 17.31% in September 2026. The stock trades at a PE of 42.08 against an industry PE of 31.56.
Nippon Life India AMC: Return on Equity of 32.83%
Nippon Life India Asset Management is one of the largest mutual fund houses in India and also runs ETFs and portfolio management services. It reported FY26 revenue of Rs 2,933.07 crore, up 16.36% year on year, and net profit of Rs 1,528.13 crore, up 18.85%. Net profit has compounded at 19.74% a year since FY22, while revenue has grown 17.56% a year. Operating margin was 68.84% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.
The stock trades at a PE of 39.03 against an industry PE of 17.70, with a return on equity of 32.83%. The dividend yield is 2.15%. In the June 2026 quarter, revenue rose 24.51% to Rs 937.08 crore and net profit grew 27.15% to Rs 503.09 crore. The share price has gained 131.06% over five years and 20.07% over the past year. Domestic institutions raised their holding from 13.45% in June 2025 to 15.49% in June 2026.
Rs 2,000-10,000 Crore Revenue Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these Rs 2,000-10,000 crore revenue stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Max Healthcare | 8,536.07 | 1,442.41 | 18.82% | 20.42% | 24.26% | 27.00% |
| MCX | 2,429.05 | 1,331.55 | 100.94% | 53.87% | 74.55% | 77.49% |
| Phoenix Mills | 4,593.55 | 1,556.61 | 15.87% | 31.04% | 58.28% | 63.42% |
| Nippon Life India AMC | 2,933.07 | 1,528.13 | 16.36% | 17.56% | 19.74% | 88.41% |
Check the Univest Screener for live data on these Rs 2,000-10,000 crore revenue stocks
Institutional Holding in Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC
Institutional holding shows who is backing these Rs 2,000-10,000 crore revenue stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%), Phoenix Mills (from 15.47% to 17.31%) and Nippon Life India AMC (from 13.45% to 15.49%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Max Healthcare | 23.71% | 41.78% | 29.96% | 4.56% | June 2026 |
| MCX | Nil | 29.84% | 50.81% | 19.34% | June 2026 |
| Phoenix Mills | 47.24% | 31.62% | 17.31% | 3.83% | September 2026 |
| Nippon Life India AMC | 71.80% | 7.04% | 15.49% | 5.67% | June 2026 |
Risks to Weigh in Rs 2,000-10,000 Crore Revenue Stocks
Being careful with Rs 2,000-10,000 crore revenue stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Nippon Life India AMC trades at a PE of 39.03 against an industry PE of 17.70, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Rs 2,000-10,000 Crore Revenue Stocks
Picking from Rs 2,000-10,000 crore revenue stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (17.70 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC live prices.
Conclusion
Among Rs 2,000-10,000 crore revenue stocks, Max Healthcare stands out for the largest market cap at Rs 85,241 crore, MCX for the highest return on equity at 46.75%, Phoenix Mills for 15.87% revenue growth in FY26 and Nippon Life India AMC for the lowest PE of the group at 39.03. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing Rs 2,000-10,000 crore revenue stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Rs 2,000-10,000 Crore Revenue Stocks to Watch
Which are the best Rs 2,000-10,000 crore revenue stocks to watch for multibagger potential?
Ans. Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC are the 4 names this list highlights, with market caps of Rs 85,241 crore, Rs 80,572 crore, Rs 68,592 crore and Rs 63,904 crore respectively. Max Healthcare is notable for the largest market cap at Rs 85,241 crore. MCX stands out for the highest return on equity at 46.75%. Phoenix Mills offers 15.87% revenue growth in FY26. Nippon Life India AMC brings the lowest PE of the group at 39.03. These are watchlist names for Rs 2,000-10,000 crore revenue stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is MCX a good stock for long-term investors?
Ans. MCX has a return on equity of 46.75%, a PE of 52.26 against an industry PE of 42.17 and a market cap of Rs 80,572 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in Rs 2,000-10,000 crore revenue stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Phoenix Mills become a multibagger from here?
Ans. Phoenix Mills has already gained 303.49% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in Rs 2,000-10,000 crore revenue stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 58.28% a year since FY22, and FY26 revenue rose 15.87%. At a PE of 42.08 against an industry PE of 31.56, valuation should be checked against that growth before investing.
What is the market cap of Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC?
Ans. As of 26 October 2026, Max Healthcare has a market cap of Rs 85,241 crore, MCX has a market cap of Rs 80,572 crore, Phoenix Mills has a market cap of Rs 68,592 crore and Nippon Life India AMC has a market cap of Rs 63,904 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on Rs 2,000-10,000 crore revenue stocks.
What are the risks of investing in Rs 2,000-10,000 crore revenue stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Nippon Life India AMC trades at a PE of 39.03 against an industry PE of 17.70, so earnings growth needs to hold up.
Why is Nippon Life India AMC trading at a PE of 39.03?
Ans. Nippon Life India AMC’s PE of 39.03 compares with an industry PE of 17.70. The market is paying a premium for a return on equity of 32.83%, profit growth of 19.74% a year since FY22 and latest-quarter profit growth of 27.15%, which also means the stock is more sensitive if growth slows. Investors in Rs 2,000-10,000 crore revenue stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Max Healthcare, MCX, Phoenix Mills and Nippon Life India AMC?
Ans. As of the latest reported quarter, FII and DII together hold 71.74% of Max Healthcare (41.78% and 29.96%), 80.65% of MCX (29.84% and 50.81%), 48.93% of Phoenix Mills (31.62% and 17.31%) and 22.53% of Nippon Life India AMC (7.04% and 15.49%). Rising institutional holding is a useful signal in Rs 2,000-10,000 crore revenue stocks, though it should be read with earnings trends rather than on its own.
